Page 132 - 2022-36-中国全科医学

http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn ·4607·

［41］OKOLI G N，RACOVITAN F，RIGHOLT C H，et al. ［52］World Health Organization.The COVID-19 vaccine tracker and
Variations in seasonal influenza vaccine effectiveness due to study landscape compiles detailed information of each COVID-19 vaccine
characteristics：a systematic review and meta-analysis of test- candidate in development by closely monitoring their progress
negative design studies［J］. Open Forum Infect Dis，2020，7（7）： through the pipeline［EB/OL］. （2021-12-10） ［2021-12-13］.
ofaa177. DOI：10.1093/ofid/ofaa177. https://www.who.int/publications/m/item/draft-landscape-of-covid-
［42］RONDY M，EL OMEIRI N，THOMPSON M G，et al. 19-candidate-vaccines.
Effectiveness of influenza vaccines in preventing severe influenza ［53］World Health Organization. 8 Vaccines Approved for Use by
illness among adults：a systematic review and meta-analysis of test- WHO［EB/OL］. （2021-12-10） ［2021-12-13］. https://
negative design case-control studies［J］. J Infect，2017，75（5）： covid19.trackvaccines.org/agency/who/.
381-394. DOI：10.1016/j.jinf.2017.09.010. ［54］THOMPSON M G，STENEHJEM E，GRANNIS S，et al.
［43］DARVISHIAN M，BIJLSMA M J，HAK E，et al. Effectiveness of Effectiveness of COVID-19 vaccines in ambulatory and inpatient
seasonal influenza vaccine in community-dwelling elderly people： care settings［J］. N Engl J Med，2021，385（15）：1355-
a meta-analysis of test-negative design case-control studies［J］. 1371. DOI：10.1056/NEJMoa2110362.
Lancet Infect Dis，2014，14（12）：1228-1239. DOI：10.1016/ ［55］KIM S S，CHUNG J R，BELONGIA E A，et al. mRNA vaccine
S1473-3099(14)70960-0. effectiveness against COVID-19 among symptomatic outpatients
［44］PEBODY R，WARBURTON F，ELLIS J，et al. Effectiveness aged ≥ 16 years in the United States，February - may 2021［J］.
of seasonal influenza vaccine for adults and children in preventing J Infect Dis，2021：jiab451. DOI：10.1093/infdis/jiab451.
laboratory-confirmed influenza in primary care in the United ［56］SKOWRONSKI D M，SETAYESHGAR S，ZOU M，et al. Single-
Kingdom：2015/16 end-of-season results［J］. Eur Commun dose mRNA vaccine effectiveness against severe acute respiratory
Dis Bull，2016，21（38）：30348. DOI：10.2807/1560-7917. syndrome coronavirus 2 （SARS-CoV-2），including alpha and
ES.2016.21.38.30348. gamma variants：a test-negative design in adults 70 years and older
［45］CHUA H，FENG S，LEWNARD J A，et al. The use of test- in British Columbia，Canada［J］. Clin Infect Dis，2022，74（7）：
negative controls to monitor vaccine effectiveness：a systematic 1158-1165. DOI：10.1093/cid/ciab616.
review of methodology［J］. Epidemiology，2020，31（1）：43- ［57］LOPEZ BERNAL J，ANDREWS N，GOWER C，et al.
64. DOI：10.1097/EDE.0000000000001116. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca
［46］UTARINI A，INDRIANI C，AHMAD R A，et al. Efficacy vaccines on COVID-19 related symptoms，hospital admissions，
of Wolbachia-infected mosquito deployments for the control of and mortality in older adults in England：test negative case-control
dengue［J］. N Engl J Med，2021，384（23）：2177-2186. study［J］. BMJ，2021，373：n1088. DOI：10.1136/bmj.n1088.
DOI：10.1056/NEJMoa2030243. ［58］CHUNG H，HE S Y，NASREEN S，et al. Effectiveness of
［47］VASILEIOU E，SHEIKH A，BUTLER C，et al. Effectiveness BNT162b2 and mRNA-1273 COVID-19 vaccines against
of influenza vaccines in asthma：a systematic review and meta- symptomatic SARS-CoV-2 infection and severe covid-19 outcomes
analysis［J］. Clin Infect Dis，2017，65（8）：1388-1395. in Ontario，Canada：test negative design study［J］. BMJ，
DOI：10.1093/cid/cix524. 2021，374：n1943. DOI：10.1136/bmj.n1943.
［48］ZIMMERMAN R K，NOWALK M P，CHUNG J，et al. 2014- ［59］RANZANI O T，HITCHINGS M D T，DORION M，et al.
2015 influenza vaccine effectiveness in the United States by vaccine Effectiveness of the CoronaVac vaccine in older adults during a
type［J］. Clin Infect Dis，2016，63（12）：1564-1573. DOI： gamma variant associated epidemic of COVID-19 in Brazil：test
10.1093/cid/ciw635. negative case-control study［J］. BMJ，2021，374：n2015.
［49］SKOWRONSKI D M，JANJUA N Z，DE SERRES G，et al. Interim DOI：10.1136/bmj.n2015.
estimates of influenza vaccine effectiveness in 2012/13 from Canada's ［60］LOPEZ BERNAL J，ANDREWS N，GOWER C，et al.
sentinel surveillance network，January 2013［J］. Euro Surveill， Effectiveness of COVID-19 vaccines against the B.1.617.2（delta）
2013，18（5）：20394. DOI：10.2807/ese.18.05.20394-en. variant［J］. N Engl J Med，2021，385（7）：585-594. DOI：
［50］DARVISHIAN M，DIJKSTRA F，VAN DOORN E，et al. 10.1056/NEJMoa2108891.
Influenza vaccine effectiveness in the Netherlands from 2003/2004 ［61］STOWE J，TESSIER E，ZHAO H，et al. Interactions between
through 2013/2014：the importance of circulating influenza virus SARS-CoV-2 and influenza，and the impact of coinfection on
types and subtypes［J］. PLoS One，2017，12（1）：e0169528. disease severity：a test-negative design［J］. Int J Epidemiol，
DOI：10.1371/journal.pone.0169528. 2021，50（4）：1124-1133. DOI：10.1093/ije/dyab081.
［51］CARVILLE K S，GRANT K A，SULLIVAN S G，et al. ［62］SIMMONS C P，FARRAR J J，VAN VINH CHAU N，et al.
Understanding influenza vaccine protection in the community： Dengue［J］. N Engl J Med，2012，366（15）：1423-1432.
an assessment of the 2013 influenza season in Victoria， DOI：10.1056/nejmra1110265.
Australia［J］. Vaccine，2015，33（2）：341-345. DOI： ［63］BOWMAN L R，DONEGAN S，MCCALL P J. Is dengue vector
10.1016/j.vaccine.2014.11.019. control deficient in effectiveness or evidence? Systematic review